FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:813-814 March 18, 1993 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Infections caused by Listeria monocytogenes have been described in patients with chronic lymphocytic leukemia (CLL). Cases have also occurred after treatment with prednisone combined with the purine analogue fludarabine¹. We have been conducting a phase I trial of another purine analogue, 2-chlorodeoxyadenosine, given intravenously as a one-hour bolus dose for five days. This drug is effective in patients with CLL refractory to fludarabine². We describe here a patient with CLL in whom listeriosis developed after treatment with 2-chlorodeoxyadenosine.

A 68-year-old woman with an eight-year history of CLL had been treated during the previous six years . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Juliusson, G., Liliemark, J., Saven, A., Piro, L., O'Brien, S. (1994). 2-Chlorodeoxyadenosine Therapy in Chronic Lymphocytic Leukemia. NEJM 330: 1828-1830 [Full Text]